KR20040045391A - 핵산 어쥬번트 - Google Patents

Info

Publication number

KR20040045391A

KR20040045391A KR10-2003-7007121A KR20037007121A KR20040045391A KR 20040045391 A KR20040045391 A KR 20040045391A KR 20037007121 A KR20037007121 A KR 20037007121A KR 20040045391 A KR20040045391 A KR 20040045391A

Authority

KR

South Korea

Prior art keywords

nucleic acid

composition

acid sequence

subunit

antigen

Prior art date

2000-11-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 251
• 102000039446 nucleic acids Human genes 0.000 title claims abstract description 74
• 108020004707 nucleic acids Proteins 0.000 title claims abstract description 74
• 239000002671 adjuvant Substances 0.000 title claims description 144
• 239000000203 mixture Substances 0.000 claims abstract description 371
• 239000000427 antigen Substances 0.000 claims abstract description 188
• 108091007433 antigens Proteins 0.000 claims abstract description 186
• 102000036639 antigens Human genes 0.000 claims abstract description 186
• 238000000034 method Methods 0.000 claims abstract description 170
• 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 134
• 108091026890 Coding region Proteins 0.000 claims abstract description 72
• 239000002095 exotoxin Substances 0.000 claims abstract description 65
• 231100000776 exotoxin Toxicity 0.000 claims abstract description 65
• OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 claims abstract description 63
• 230000028993 immune response Effects 0.000 claims abstract description 58
• 230000001580 bacterial effect Effects 0.000 claims abstract description 38
• 230000002708 enhancing effect Effects 0.000 claims abstract description 9
• 239000002245 particle Substances 0.000 claims description 149
• 229910052737 gold Inorganic materials 0.000 claims description 139
• 239000010931 gold Substances 0.000 claims description 139
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 134
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 128
• 239000013600 plasmid vector Substances 0.000 claims description 71
• 108010049048 Cholera Toxin Proteins 0.000 claims description 55
• 102000009016 Cholera Toxin Human genes 0.000 claims description 55
• 241001465754 Metazoa Species 0.000 claims description 48
• 229960005486 vaccine Drugs 0.000 claims description 44
• 241000700605 Viruses Species 0.000 claims description 41
• 239000003053 toxin Substances 0.000 claims description 41
• 231100000765 toxin Toxicity 0.000 claims description 41
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 35
• 238000010171 animal model Methods 0.000 claims description 31
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 29
• 241000894006 Bacteria Species 0.000 claims description 23
• 238000002347 injection Methods 0.000 claims description 21
• 239000007924 injection Substances 0.000 claims description 21
• 230000001404 mediated effect Effects 0.000 claims description 20
• 230000000694 effects Effects 0.000 claims description 19
• 241000588724 Escherichia coli Species 0.000 claims description 14
• 239000000147 enterotoxin Substances 0.000 claims description 14
• 231100000655 enterotoxin Toxicity 0.000 claims description 14
• 244000052769 pathogen Species 0.000 claims description 13
• 101710146739 Enterotoxin Proteins 0.000 claims description 12
• 238000004519 manufacturing process Methods 0.000 claims description 12
• 238000001890 transfection Methods 0.000 claims description 12
• 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 11
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 11
• 210000004899 c-terminal region Anatomy 0.000 claims description 9
• 239000002502 liposome Substances 0.000 claims description 9
• 238000000576 coating method Methods 0.000 claims description 8
• 239000003814 drug Substances 0.000 claims description 8
• 239000011248 coating agent Substances 0.000 claims description 7
• 229910052751 metal Inorganic materials 0.000 claims description 7
• 239000002184 metal Substances 0.000 claims description 7
• 230000003071 parasitic effect Effects 0.000 claims description 7
• 230000001717 pathogenic effect Effects 0.000 claims description 6
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 6
• 230000037317 transdermal delivery Effects 0.000 claims description 6
• 239000003981 vehicle Substances 0.000 claims description 5
• 102000004357 Transferases Human genes 0.000 claims description 4
• 108090000992 Transferases Proteins 0.000 claims description 4
• 238000012239 gene modification Methods 0.000 claims description 3
• 230000005017 genetic modification Effects 0.000 claims description 3
• 235000013617 genetically modified food Nutrition 0.000 claims description 3
• 231100000331 toxic Toxicity 0.000 claims description 3
• 230000002588 toxic effect Effects 0.000 claims description 3
• 239000000546 pharmaceutical excipient Substances 0.000 claims 4
• 239000010419 fine particle Substances 0.000 claims 2
• 108700026244 Open Reading Frames Proteins 0.000 claims 1
• 239000013598 vector Substances 0.000 abstract description 211
• 108020004414 DNA Proteins 0.000 description 172
• 238000009472 formulation Methods 0.000 description 145
• 239000013612 plasmid Substances 0.000 description 77
• 210000004027 cell Anatomy 0.000 description 76
• 102000040430 polynucleotide Human genes 0.000 description 52
• 108091033319 polynucleotide Proteins 0.000 description 52
• 239000002157 polynucleotide Substances 0.000 description 52
• 101710132601 Capsid protein Proteins 0.000 description 45
• 108090000623 proteins and genes Proteins 0.000 description 44
• 238000003752 polymerase chain reaction Methods 0.000 description 42
• 239000012634 fragment Substances 0.000 description 39
• 238000006243 chemical reaction Methods 0.000 description 38
• 230000014509 gene expression Effects 0.000 description 38
• 108700012359 toxins Proteins 0.000 description 38
• 108010041986 DNA Vaccines Proteins 0.000 description 31
• 229940021995 DNA vaccine Drugs 0.000 description 31
• 239000002773 nucleotide Substances 0.000 description 31
• 125000003729 nucleotide group Chemical group 0.000 description 31
• 102100037850 Interferon gamma Human genes 0.000 description 25
• 108010074328 Interferon-gamma Proteins 0.000 description 25
• 239000013566 allergen Substances 0.000 description 25
• 241000699670 Mus sp. Species 0.000 description 24
• 238000011081 inoculation Methods 0.000 description 22
• 150000001413 amino acids Chemical class 0.000 description 21
• 238000002360 preparation method Methods 0.000 description 21
• 235000018102 proteins Nutrition 0.000 description 20
• 102000004169 proteins and genes Human genes 0.000 description 20
• 230000000240 adjuvant effect Effects 0.000 description 19
• 230000004044 response Effects 0.000 description 19
• 241000725303 Human immunodeficiency virus Species 0.000 description 17
• 239000000047 product Substances 0.000 description 17
• 210000002966 serum Anatomy 0.000 description 17
• 239000000243 solution Substances 0.000 description 17
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 16
• 239000000654 additive Substances 0.000 description 16
• 235000001014 amino acid Nutrition 0.000 description 16
• 101710130522 mRNA export factor Proteins 0.000 description 16
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 15
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
• 239000000969 carrier Substances 0.000 description 14
• ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 14
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
• 241000701022 Cytomegalovirus Species 0.000 description 13
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
• 208000002672 hepatitis B Diseases 0.000 description 13
• 230000001965 increasing effect Effects 0.000 description 13
• 238000010367 cloning Methods 0.000 description 12
• 210000004962 mammalian cell Anatomy 0.000 description 12
• 230000028327 secretion Effects 0.000 description 12
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 11
• 230000003053 immunization Effects 0.000 description 11
• 239000000463 material Substances 0.000 description 11
• 210000004988 splenocyte Anatomy 0.000 description 11
• 238000012360 testing method Methods 0.000 description 11
• 238000012546 transfer Methods 0.000 description 11
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
• 229920001213 Polysorbate 20 Polymers 0.000 description 10
• 239000000306 component Substances 0.000 description 10
• 238000010790 dilution Methods 0.000 description 10
• 239000012895 dilution Substances 0.000 description 10
• 238000002649 immunization Methods 0.000 description 10
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 10
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 10
• 230000010076 replication Effects 0.000 description 10
• 239000000126 substance Substances 0.000 description 10
• 238000005406 washing Methods 0.000 description 10
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 9
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 9
• 230000000890 antigenic effect Effects 0.000 description 9
• 239000007788 liquid Substances 0.000 description 9
• 230000007246 mechanism Effects 0.000 description 9
• 230000008488 polyadenylation Effects 0.000 description 9
• 229960000187 tissue plasminogen activator Drugs 0.000 description 9
• 230000003612 virological effect Effects 0.000 description 9
• 239000003795 chemical substances by application Substances 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 238000001556 precipitation Methods 0.000 description 8
• 210000001519 tissue Anatomy 0.000 description 8
• 238000011282 treatment Methods 0.000 description 8
• 239000013603 viral vector Substances 0.000 description 8
• 241000283707 Capra Species 0.000 description 7
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
• 238000011510 Elispot assay Methods 0.000 description 7
• 241000699666 Mus <mouse, genus> Species 0.000 description 7
• 230000024932 T cell mediated immunity Effects 0.000 description 7
• 229920006355 Tefzel Polymers 0.000 description 7
• 238000002835 absorbance Methods 0.000 description 7
• 230000027455 binding Effects 0.000 description 7
• 229960002685 biotin Drugs 0.000 description 7
• 239000011616 biotin Substances 0.000 description 7
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 7
• 201000010099 disease Diseases 0.000 description 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 7
• 210000002615 epidermis Anatomy 0.000 description 7
• QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical compound C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 7
• 238000002474 experimental method Methods 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 230000035772 mutation Effects 0.000 description 7
• 239000000523 sample Substances 0.000 description 7
• 210000003491 skin Anatomy 0.000 description 7
• 229940063673 spermidine Drugs 0.000 description 7
• 210000000952 spleen Anatomy 0.000 description 7
• 231100000419 toxicity Toxicity 0.000 description 7
• 230000001988 toxicity Effects 0.000 description 7
• WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 7
• 229910052721 tungsten Inorganic materials 0.000 description 7
• 239000010937 tungsten Substances 0.000 description 7
• 241000701161 unidentified adenovirus Species 0.000 description 7
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
• 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
• 101000719019 Homo sapiens Glutamyl aminopeptidase Proteins 0.000 description 6
• 206010028980 Neoplasm Diseases 0.000 description 6
• 241000700159 Rattus Species 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 239000000872 buffer Substances 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 239000002299 complementary DNA Substances 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 108020004999 messenger RNA Proteins 0.000 description 6
• 229920001184 polypeptide Polymers 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• -1 rRNAs Proteins 0.000 description 6
• 230000001105 regulatory effect Effects 0.000 description 6
• 238000013518 transcription Methods 0.000 description 6
• 230000035897 transcription Effects 0.000 description 6
• 238000013519 translation Methods 0.000 description 6
• UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 5
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
• 238000012286 ELISA Assay Methods 0.000 description 5
• 241000233866 Fungi Species 0.000 description 5
• 108090000978 Interleukin-4 Proteins 0.000 description 5
• 210000001744 T-lymphocyte Anatomy 0.000 description 5
• 230000005875 antibody response Effects 0.000 description 5
• 235000020958 biotin Nutrition 0.000 description 5
• 108010006025 bovine growth hormone Proteins 0.000 description 5
• 238000011260 co-administration Methods 0.000 description 5
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 238000011161 development Methods 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 239000012091 fetal bovine serum Substances 0.000 description 5
• 239000007789 gas Substances 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 210000004379 membrane Anatomy 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 150000003839 salts Chemical class 0.000 description 5
• 239000012646 vaccine adjuvant Substances 0.000 description 5
• 231100000699 Bacterial toxin Toxicity 0.000 description 4
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
• 238000011238 DNA vaccination Methods 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• 102100034349 Integrase Human genes 0.000 description 4
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 4
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 4
• 241000282887 Suidae Species 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• 210000001015 abdomen Anatomy 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 239000000688 bacterial toxin Substances 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 210000004369 blood Anatomy 0.000 description 4
• 239000008280 blood Substances 0.000 description 4
• 239000007853 buffer solution Substances 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 238000003776 cleavage reaction Methods 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 239000013604 expression vector Substances 0.000 description 4
• 230000028996 humoral immune response Effects 0.000 description 4
• 230000036039 immunity Effects 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 238000011065 in-situ storage Methods 0.000 description 4
• 206010022000 influenza Diseases 0.000 description 4
• 229940065638 intron a Drugs 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 238000011068 loading method Methods 0.000 description 4
• 235000013336 milk Nutrition 0.000 description 4
• 239000008267 milk Substances 0.000 description 4
• 210000004080 milk Anatomy 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 238000004806 packaging method and process Methods 0.000 description 4
• 239000000825 pharmaceutical preparation Substances 0.000 description 4
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
• 229920001223 polyethylene glycol Polymers 0.000 description 4
• 239000002243 precursor Substances 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 230000001177 retroviral effect Effects 0.000 description 4
• 230000007017 scission Effects 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
• 239000003104 tissue culture media Substances 0.000 description 4
• 230000005030 transcription termination Effects 0.000 description 4
• 239000013607 AAV vector Substances 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
• 108020004705 Codon Proteins 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 108010053187 Diphtheria Toxin Proteins 0.000 description 3
• 102000016607 Diphtheria Toxin Human genes 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 108090000288 Glycoproteins Proteins 0.000 description 3
• 102000003886 Glycoproteins Human genes 0.000 description 3
• 241000711549 Hepacivirus C Species 0.000 description 3
• 241000700721 Hepatitis B virus Species 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• 108700020121 Human Immunodeficiency Virus-1 rev Proteins 0.000 description 3
• 241000712431 Influenza A virus Species 0.000 description 3
• 102100021244 Integral membrane protein GPR180 Human genes 0.000 description 3
• 201000005505 Measles Diseases 0.000 description 3
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 241000713311 Simian immunodeficiency virus Species 0.000 description 3
• 101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 3
• 108091081024 Start codon Proteins 0.000 description 3
• 108010090804 Streptavidin Proteins 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 229910000389 calcium phosphate Inorganic materials 0.000 description 3
• 235000011010 calcium phosphates Nutrition 0.000 description 3
• 230000007969 cellular immunity Effects 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 239000008367 deionised water Substances 0.000 description 3
• 229910021641 deionized water Inorganic materials 0.000 description 3
• 238000002716 delivery method Methods 0.000 description 3
• 238000001514 detection method Methods 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 239000001307 helium Substances 0.000 description 3
• 229910052734 helium Inorganic materials 0.000 description 3
• SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
• 208000029570 hepatitis D virus infection Diseases 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 238000003018 immunoassay Methods 0.000 description 3
• 208000015181 infectious disease Diseases 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 238000010255 intramuscular injection Methods 0.000 description 3
• 239000007927 intramuscular injection Substances 0.000 description 3
• 239000004816 latex Substances 0.000 description 3
• 229920000126 latex Polymers 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 150000002739 metals Chemical class 0.000 description 3
• 238000010369 molecular cloning Methods 0.000 description 3
• 210000004400 mucous membrane Anatomy 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 238000010647 peptide synthesis reaction Methods 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 231100000614 poison Toxicity 0.000 description 3
• 239000002574 poison Substances 0.000 description 3
• 239000002244 precipitate Substances 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 230000002685 pulmonary effect Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 230000000241 respiratory effect Effects 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 235000020183 skimmed milk Nutrition 0.000 description 3
• 241000894007 species Species 0.000 description 3
• PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical class NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 3
• 239000007921 spray Substances 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• 239000003656 tris buffered saline Substances 0.000 description 3
• 241001430294 unidentified retrovirus Species 0.000 description 3
• 239000011534 wash buffer Substances 0.000 description 3
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
• LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 2
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 2
• IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 208000004881 Amebiasis Diseases 0.000 description 2
• 206010001980 Amoebiasis Diseases 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
• 206010008631 Cholera Diseases 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 2
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
• 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 2
• 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 208000001840 Dandruff Diseases 0.000 description 2
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 241000991587 Enterovirus C Species 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
• 108091006027 G proteins Proteins 0.000 description 2
• 241000531123 GB virus C Species 0.000 description 2
• 102000030782 GTP binding Human genes 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 208000031886 HIV Infections Diseases 0.000 description 2
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 2
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 2
• 241000724675 Hepatitis E virus Species 0.000 description 2
• 241000709721 Hepatovirus A Species 0.000 description 2
• 208000009889 Herpes Simplex Diseases 0.000 description 2
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
• 239000004705 High-molecular-weight polyethylene Substances 0.000 description 2
• 108010000521 Human Growth Hormone Proteins 0.000 description 2
• 102000002265 Human Growth Hormone Human genes 0.000 description 2
• 239000000854 Human Growth Hormone Substances 0.000 description 2
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 241000712079 Measles morbillivirus Species 0.000 description 2
• 241000711386 Mumps virus Species 0.000 description 2
• 108010086093 Mung Bean Nuclease Proteins 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 101001044384 Mus musculus Interferon gamma Proteins 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
• 102000003992 Peroxidases Human genes 0.000 description 2
• 201000005702 Pertussis Diseases 0.000 description 2
• 108010081690 Pertussis Toxin Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 102000015439 Phospholipases Human genes 0.000 description 2
• 108010064785 Phospholipases Proteins 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
• 241000589516 Pseudomonas Species 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 206010057190 Respiratory tract infections Diseases 0.000 description 2
• 241000702670 Rotavirus Species 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• 108010006785 Taq Polymerase Proteins 0.000 description 2
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
• 101800001690 Transmembrane protein gp41 Proteins 0.000 description 2
• 206010044608 Trichiniasis Diseases 0.000 description 2
• 241000607626 Vibrio cholerae Species 0.000 description 2
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 2
• 108010067390 Viral Proteins Proteins 0.000 description 2
• 108020000999 Viral RNA Proteins 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 238000003556 assay Methods 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 2
• SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 2
• 244000309466 calf Species 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 239000001569 carbon dioxide Substances 0.000 description 2
• 229910002092 carbon dioxide Inorganic materials 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 239000006285 cell suspension Substances 0.000 description 2
• 230000036755 cellular response Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 235000013330 chicken meat Nutrition 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 235000015165 citric acid Nutrition 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 239000002537 cosmetic Substances 0.000 description 2
• 238000005520 cutting process Methods 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 229940079920 digestives acid preparations Drugs 0.000 description 2
• 231100000676 disease causative agent Toxicity 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 239000000428 dust Substances 0.000 description 2
• 235000013601 eggs Nutrition 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 239000000839 emulsion Substances 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 229940088598 enzyme Drugs 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 239000013568 food allergen Substances 0.000 description 2
• 238000004108 freeze drying Methods 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 150000002334 glycols Chemical class 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 210000002443 helper t lymphocyte Anatomy 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• 229960003160 hyaluronic acid Drugs 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 229910052500 inorganic mineral Inorganic materials 0.000 description 2
• 229960000367 inositol Drugs 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 210000004779 membrane envelope Anatomy 0.000 description 2
• 238000005374 membrane filtration Methods 0.000 description 2
• 239000011707 mineral Substances 0.000 description 2
• 239000002480 mineral oil Substances 0.000 description 2
• 235000010446 mineral oil Nutrition 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 238000001823 molecular biology technique Methods 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 229940023146 nucleic acid vaccine Drugs 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 239000006174 pH buffer Substances 0.000 description 2
• 244000045947 parasite Species 0.000 description 2
• 239000000816 peptidomimetic Substances 0.000 description 2
• 108040007629 peroxidase activity proteins Proteins 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 229910052697 platinum Inorganic materials 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 230000001376 precipitating effect Effects 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 102000016914 ras Proteins Human genes 0.000 description 2
• 239000011535 reaction buffer Substances 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 108700004030 rev Genes Proteins 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 235000015424 sodium Nutrition 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 229910000162 sodium phosphate Inorganic materials 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 229940031626 subunit vaccine Drugs 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 239000011975 tartaric acid Substances 0.000 description 2
• 235000002906 tartaric acid Nutrition 0.000 description 2
• 229940113082 thymine Drugs 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 208000003982 trichinellosis Diseases 0.000 description 2
• 201000007588 trichinosis Diseases 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 241000712461 unidentified influenza virus Species 0.000 description 2
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
• KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 1
• VKLOPQHLJNFYKK-UHFFFAOYSA-N 3-dodecylsulfanylpropanoic acid Chemical compound CCCCCCCCCCCCSCCC(O)=O VKLOPQHLJNFYKK-UHFFFAOYSA-N 0.000 description 1
• GMOGICAFJFPMNS-UHFFFAOYSA-N 4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1CCNCCCNCCNCCC1 GMOGICAFJFPMNS-UHFFFAOYSA-N 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• XZKIHKMTEMTJQX-UHFFFAOYSA-L 4-nitrophenyl phosphate(2-) Chemical compound [O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-L 0.000 description 1
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
• 102000009062 ADP Ribose Transferases Human genes 0.000 description 1
• 108010049290 ADP Ribose Transferases Proteins 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
• 241000186361 Actinobacteria <class> Species 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 1
• 241000004176 Alphacoronavirus Species 0.000 description 1
• 241000223600 Alternaria Species 0.000 description 1
• 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
• 241001465677 Ancylostomatoidea Species 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 241000712892 Arenaviridae Species 0.000 description 1
• 235000003097 Artemisia absinthium Nutrition 0.000 description 1
• 240000001851 Artemisia dracunculus Species 0.000 description 1
• 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
• 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
• 201000002909 Aspergillosis Diseases 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 208000036641 Aspergillus infections Diseases 0.000 description 1
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
• 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 208000004429 Bacillary Dysentery Diseases 0.000 description 1
• 235000018185 Betula X alpestris Nutrition 0.000 description 1
• 235000018212 Betula X uliginosa Nutrition 0.000 description 1
• 241000702628 Birnaviridae Species 0.000 description 1
• 241001674044 Blattodea Species 0.000 description 1
• 241000588807 Bordetella Species 0.000 description 1
• 241000588780 Bordetella parapertussis Species 0.000 description 1
• 241000588832 Bordetella pertussis Species 0.000 description 1
• 208000014644 Brain disease Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 241001609030 Brosme brosme Species 0.000 description 1
• 241000589562 Brucella Species 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 101150114515 CTBS gene Proteins 0.000 description 1
• 101000946068 Caenorhabditis elegans Ceramide glucosyltransferase 3 Proteins 0.000 description 1
• 241000714198 Caliciviridae Species 0.000 description 1
• 241001164374 Calyx Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 206010007134 Candida infections Diseases 0.000 description 1
• 241000723418 Carya Species 0.000 description 1
• 244000068645 Carya illinoensis Species 0.000 description 1
• 235000009025 Carya illinoensis Nutrition 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 240000001817 Cereus hexagonus Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 102100029173 Choline-phosphate cytidylyltransferase B Human genes 0.000 description 1
• 101710100756 Choline-phosphate cytidylyltransferase B Proteins 0.000 description 1
• 241000193163 Clostridioides difficile Species 0.000 description 1
• 241000193155 Clostridium botulinum Species 0.000 description 1
• 241000193468 Clostridium perfringens Species 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 206010010071 Coma Diseases 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 241000223935 Cryptosporidium Species 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 125000000824 D-ribofuranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 108010061629 Dermatophagoides pteronyssinus antigen p 1 Proteins 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 208000032274 Encephalopathy Diseases 0.000 description 1
• 101710121417 Envelope glycoprotein Proteins 0.000 description 1
• 101710204610 Envelope glycoprotein gp160 Proteins 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 241000234642 Festuca Species 0.000 description 1
• 201000006353 Filariasis Diseases 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 241000223218 Fusarium Species 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 206010048461 Genital infection Diseases 0.000 description 1
• 241000224466 Giardia Species 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
• 206010018693 Granuloma inguinale Diseases 0.000 description 1
• 108010035452 HLA-A1 Antigen Proteins 0.000 description 1
• 108010074032 HLA-A2 Antigen Proteins 0.000 description 1
• 102000025850 HLA-A2 Antigen Human genes 0.000 description 1
• 241000186568 Hathewaya limosa Species 0.000 description 1
• 241000589989 Helicobacter Species 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• 208000005331 Hepatitis D Diseases 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
• 101001005728 Homo sapiens Melanoma-associated antigen 1 Proteins 0.000 description 1
• 101001005718 Homo sapiens Melanoma-associated antigen 2 Proteins 0.000 description 1
• 101001005719 Homo sapiens Melanoma-associated antigen 3 Proteins 0.000 description 1
• 101001005720 Homo sapiens Melanoma-associated antigen 4 Proteins 0.000 description 1
• 101001057131 Homo sapiens Melanoma-associated antigen D4 Proteins 0.000 description 1
• 241000441510 Hormodendrum Species 0.000 description 1
• 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
• 241000598171 Human adenovirus sp. Species 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000701027 Human herpesvirus 6 Species 0.000 description 1
• 241000257303 Hymenoptera Species 0.000 description 1
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 241000588747 Klebsiella pneumoniae Species 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
• 108010010995 MART-1 Antigen Proteins 0.000 description 1
• 102000016200 MART-1 Antigen Human genes 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 108010071463 Melanoma-Specific Antigens Proteins 0.000 description 1
• 102000007557 Melanoma-Specific Antigens Human genes 0.000 description 1
• 102100025050 Melanoma-associated antigen 1 Human genes 0.000 description 1
• 102100025081 Melanoma-associated antigen 2 Human genes 0.000 description 1
• 102100025082 Melanoma-associated antigen 3 Human genes 0.000 description 1
• 102100025077 Melanoma-associated antigen 4 Human genes 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 241000588655 Moraxella catarrhalis Species 0.000 description 1
• 241000235395 Mucor Species 0.000 description 1
• 208000005647 Mumps Diseases 0.000 description 1
• 241000282339 Mustela Species 0.000 description 1
• 101000783356 Naja sputatrix Cytotoxin Proteins 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 241000244206 Nematoda Species 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 241000187654 Nocardia Species 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 241000243985 Onchocerca volvulus Species 0.000 description 1
• 241000712464 Orthomyxoviridae Species 0.000 description 1
• 206010033078 Otitis media Diseases 0.000 description 1
• 108010036616 P18-I10 peptide Proteins 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241000711504 Paramyxoviridae Species 0.000 description 1
• 241000606860 Pasteurella Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 241000150350 Peribunyaviridae Species 0.000 description 1
• 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
• 244000046052 Phaseolus vulgaris Species 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 240000004713 Pisum sativum Species 0.000 description 1
• 235000010582 Pisum sativum Nutrition 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 244000239204 Plantago lanceolata Species 0.000 description 1
• 235000010503 Plantago lanceolata Nutrition 0.000 description 1
• 102100038124 Plasminogen Human genes 0.000 description 1
• 241000233872 Pneumocystis carinii Species 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102000029797 Prion Human genes 0.000 description 1
• 108091000054 Prion Proteins 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 101000762949 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Exotoxin A Proteins 0.000 description 1
• 241000219492 Quercus Species 0.000 description 1
• 238000002123 RNA extraction Methods 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 244000088415 Raphanus sativus Species 0.000 description 1
• 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 241000702247 Reoviridae Species 0.000 description 1
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 206010039438 Salmonella Infections Diseases 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 241000242678 Schistosoma Species 0.000 description 1
• 235000007238 Secale cereale Nutrition 0.000 description 1
• 244000082988 Secale cereale Species 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 206010040550 Shigella infections Diseases 0.000 description 1
• 102100035254 Sodium- and chloride-dependent GABA transporter 3 Human genes 0.000 description 1
• 101710104417 Sodium- and chloride-dependent GABA transporter 3 Proteins 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 108010088897 Staphylococcus aureus epidermal cell differentiation inhibitor Proteins 0.000 description 1
• 241000122938 Strongylus vulgaris Species 0.000 description 1
• 241000244155 Taenia Species 0.000 description 1
• 244000204900 Talipariti tiliaceum Species 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 244000152045 Themeda triandra Species 0.000 description 1
• 241000159241 Toxicodendron Species 0.000 description 1
• 241000223996 Toxoplasma Species 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 241000242541 Trematoda Species 0.000 description 1
• 241000589886 Treponema Species 0.000 description 1
• 208000005448 Trichomonas Infections Diseases 0.000 description 1
• 206010044620 Trichomoniasis Diseases 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 208000037386 Typhoid Diseases 0.000 description 1
• 102000003425 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 241001106462 Ulmus Species 0.000 description 1
• 244000274883 Urtica dioica Species 0.000 description 1
• 235000009108 Urtica dioica Nutrition 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 241000256856 Vespidae Species 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• 238000003916 acid precipitation Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 201000007691 actinomycosis Diseases 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 238000007605 air drying Methods 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 244000037640 animal pathogen Species 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 239000001138 artemisia absinthium Substances 0.000 description 1
• 208000010668 atopic eczema Diseases 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 239000003659 bee venom Substances 0.000 description 1
• IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 238000010170 biological method Methods 0.000 description 1
• 239000013575 birch pollen allergen Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 238000007664 blowing Methods 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 229960003150 bupivacaine Drugs 0.000 description 1
• 201000003984 candidiasis Diseases 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000002340 cardiotoxin Substances 0.000 description 1
• 231100000677 cardiotoxin Toxicity 0.000 description 1
• 210000000845 cartilage Anatomy 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 235000013351 cheese Nutrition 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 239000003593 chromogenic compound Substances 0.000 description 1
• 208000017580 chronic wasting disease Diseases 0.000 description 1
• 238000012411 cloning technique Methods 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 238000010968 computed tomography angiography Methods 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 230000008094 contradictory effect Effects 0.000 description 1
• 239000000599 controlled substance Substances 0.000 description 1
• 229940028617 conventional vaccine Drugs 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 235000013365 dairy product Nutrition 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 239000013024 dilution buffer Substances 0.000 description 1
• 229910001873 dinitrogen Inorganic materials 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 235000012489 doughnuts Nutrition 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 238000010291 electrical method Methods 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 230000000688 enterotoxigenic effect Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 239000003256 environmental substance Substances 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• MAUQAXOHCVNUMX-BUHFOSPRSA-N ethyl (e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CCOC(=O)CC(O)CC(O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 MAUQAXOHCVNUMX-BUHFOSPRSA-N 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 239000002360 explosive Substances 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 210000001508 eye Anatomy 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 210000003746 feather Anatomy 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• QPJBWNIQKHGLAU-IQZHVAEDSA-N ganglioside GM1 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 QPJBWNIQKHGLAU-IQZHVAEDSA-N 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 230000008571 general function Effects 0.000 description 1
• 201000006592 giardiasis Diseases 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 150000002339 glycosphingolipids Chemical class 0.000 description 1
• 229940111120 gold preparations Drugs 0.000 description 1
• ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 239000000118 hair dye Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 229940037467 helicobacter pylori Drugs 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 229930186900 holotoxin Natural products 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 244000052637 human pathogen Species 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 229940127121 immunoconjugate Drugs 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 230000001024 immunotherapeutic effect Effects 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 201000006747 infectious mononucleosis Diseases 0.000 description 1
• 229960003971 influenza vaccine Drugs 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 230000031261 interleukin-10 production Effects 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical group [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 235000021332 kidney beans Nutrition 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 230000001926 lymphatic effect Effects 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 208000010805 mumps infectious disease Diseases 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 210000001167 myeloblast Anatomy 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 235000014571 nuts Nutrition 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 208000002042 onchocerciasis Diseases 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 108700025694 p53 Genes Proteins 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 235000020232 peanut Nutrition 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000002304 perfume Substances 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
• 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 108010011110 polyarginine Proteins 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 108010055896 polyornithine Proteins 0.000 description 1
• 229920002714 polyornithine Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 101150098213 rev gene Proteins 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 239000005060 rubber Substances 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
• 229960001860 salicylate Drugs 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 206010039447 salmonellosis Diseases 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 208000008864 scrapie Diseases 0.000 description 1
• 235000014102 seafood Nutrition 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 235000015170 shellfish Nutrition 0.000 description 1
• 201000005113 shigellosis Diseases 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 238000004513 sizing Methods 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 229940063675 spermine Drugs 0.000 description 1
• 210000004989 spleen cell Anatomy 0.000 description 1
• 230000003393 splenic effect Effects 0.000 description 1
• 238000001694 spray drying Methods 0.000 description 1
• 238000005507 spraying Methods 0.000 description 1
• 230000007480 spreading Effects 0.000 description 1
• 238000003892 spreading Methods 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 229940124530 sulfonamide Drugs 0.000 description 1
• 150000003456 sulfonamides Chemical class 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000013595 supernatant sample Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 229940031572 toxoid vaccine Drugs 0.000 description 1
• 238000013271 transdermal drug delivery Methods 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 229950002929 trinitrophenol Drugs 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 230000006433 tumor necrosis factor production Effects 0.000 description 1
• 230000009959 type I hypersensitivity Effects 0.000 description 1
• 201000008297 typhoid fever Diseases 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 238000001291 vacuum drying Methods 0.000 description 1
• 244000052613 viral pathogen Species 0.000 description 1
• 230000017613 viral reproduction Effects 0.000 description 1
• 210000002845 virion Anatomy 0.000 description 1
• 238000003260 vortexing Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 210000002268 wool Anatomy 0.000 description 1
• 229910000859 α-Fe Inorganic materials 0.000 description 1